Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794924445> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2794924445 abstract "Background: Oral P2Y12 inhibitors including clopidogrel, prasugrel, and ticagrelor are FDA-approved for patients presenting with acute coronary syndrome. Due to systematic exclusion of patients with end stage renal disease (ESRD) on outpatient dialysis from major trials, scarce data exist to report contemporary use of these drugs in ESRD patients.Study design: Retrospective chart review of patient records.Setting and participants: From 2011-2015, 848 ESRD patients (32%) had prescriptions for oral P2Y12 inhibitors such as clopidogrel, prasugrel, and ticagrelor. Differences in patient characteristics as well as major adverse events (MAEs) defined as a composite of new coronary stent placement, heart valve replacement, coronary artery bypass graft or amputation; and all-cause death, nose and gastrointestinal (GI) bleeding were collected.Results: Of the 85 patient records that were reviewed, there were 68.2% males, 66.7% whites, 21.4% African Americans and 9% on peritoneal dialysis. There were no differences in baseline characteristics of patients who were prescribed the three drugs. 18 (21.2%) deaths, 57 (67.1%) MAEs, 9 (10.6%) nose bleeds and 13 (15.3%) GI bleeds were identified over 16.5 months follow up. There was no difference in clinical outcome variables between the three groups.Conclusion: Oral P2Y12 inhibitors were commonly prescribed to ESRD patients despite the inadequacy of data and there were no differences in the profiles of ESRD patients who were prescribed the three drugs or their outcome variables. All-cause death, MAEs, nose and GI bleeds were common in these patients. Future studies are needed to investigate clinical benefits and risks associated with use of P2Y12 inhibitors in this high-risk patient population." @default.
- W2794924445 created "2018-04-06" @default.
- W2794924445 creator A5012788767 @default.
- W2794924445 creator A5013793636 @default.
- W2794924445 creator A5034061309 @default.
- W2794924445 creator A5050019343 @default.
- W2794924445 creator A5072503999 @default.
- W2794924445 creator A5074901638 @default.
- W2794924445 creator A5083033844 @default.
- W2794924445 date "2017-01-01" @default.
- W2794924445 modified "2023-09-27" @default.
- W2794924445 title "Contemporary Profile of Chronic Dialysis Patients Receiving Oral P2Y12 Inhibitors: A Single Center Experience" @default.
- W2794924445 hasPublicationYear "2017" @default.
- W2794924445 type Work @default.
- W2794924445 sameAs 2794924445 @default.
- W2794924445 citedByCount "0" @default.
- W2794924445 crossrefType "journal-article" @default.
- W2794924445 hasAuthorship W2794924445A5012788767 @default.
- W2794924445 hasAuthorship W2794924445A5013793636 @default.
- W2794924445 hasAuthorship W2794924445A5034061309 @default.
- W2794924445 hasAuthorship W2794924445A5050019343 @default.
- W2794924445 hasAuthorship W2794924445A5072503999 @default.
- W2794924445 hasAuthorship W2794924445A5074901638 @default.
- W2794924445 hasAuthorship W2794924445A5083033844 @default.
- W2794924445 hasConcept C126322002 @default.
- W2794924445 hasConcept C141071460 @default.
- W2794924445 hasConcept C197934379 @default.
- W2794924445 hasConcept C2777028646 @default.
- W2794924445 hasConcept C2777698277 @default.
- W2794924445 hasConcept C2777849778 @default.
- W2794924445 hasConcept C2778213512 @default.
- W2794924445 hasConcept C2779978075 @default.
- W2794924445 hasConcept C2780890252 @default.
- W2794924445 hasConcept C500558357 @default.
- W2794924445 hasConcept C71924100 @default.
- W2794924445 hasConceptScore W2794924445C126322002 @default.
- W2794924445 hasConceptScore W2794924445C141071460 @default.
- W2794924445 hasConceptScore W2794924445C197934379 @default.
- W2794924445 hasConceptScore W2794924445C2777028646 @default.
- W2794924445 hasConceptScore W2794924445C2777698277 @default.
- W2794924445 hasConceptScore W2794924445C2777849778 @default.
- W2794924445 hasConceptScore W2794924445C2778213512 @default.
- W2794924445 hasConceptScore W2794924445C2779978075 @default.
- W2794924445 hasConceptScore W2794924445C2780890252 @default.
- W2794924445 hasConceptScore W2794924445C500558357 @default.
- W2794924445 hasConceptScore W2794924445C71924100 @default.
- W2794924445 hasIssue "3" @default.
- W2794924445 hasLocation W27949244451 @default.
- W2794924445 hasOpenAccess W2794924445 @default.
- W2794924445 hasPrimaryLocation W27949244451 @default.
- W2794924445 hasRelatedWork W1622619388 @default.
- W2794924445 hasRelatedWork W2007701394 @default.
- W2794924445 hasRelatedWork W2007726463 @default.
- W2794924445 hasRelatedWork W2016921425 @default.
- W2794924445 hasRelatedWork W2020141939 @default.
- W2794924445 hasRelatedWork W2023864095 @default.
- W2794924445 hasRelatedWork W2038491237 @default.
- W2794924445 hasRelatedWork W2101495014 @default.
- W2794924445 hasRelatedWork W2185654639 @default.
- W2794924445 hasRelatedWork W2231277951 @default.
- W2794924445 hasRelatedWork W2292491867 @default.
- W2794924445 hasRelatedWork W2354114648 @default.
- W2794924445 hasRelatedWork W2405573861 @default.
- W2794924445 hasRelatedWork W2461471803 @default.
- W2794924445 hasRelatedWork W2777435441 @default.
- W2794924445 hasRelatedWork W2946247069 @default.
- W2794924445 hasRelatedWork W2973248400 @default.
- W2794924445 hasRelatedWork W3111970188 @default.
- W2794924445 hasRelatedWork W3176394930 @default.
- W2794924445 hasRelatedWork W3212730832 @default.
- W2794924445 hasVolume "1" @default.
- W2794924445 isParatext "false" @default.
- W2794924445 isRetracted "false" @default.
- W2794924445 magId "2794924445" @default.
- W2794924445 workType "article" @default.